Improving Clinical Data Accessibility Through Automated FHIR Data Transformation Tools
Adarsh Pawar, Yuqiao Meng, Luoxi Tang, Zhaohan Xi
TL;DR
This paper tackles the barrier of interpreting and reusing FHIR data by providing a browser-native transformation tool that converts raw FHIR JSON into human-readable reports and visualizations. It introduces a client-side pipeline that ingests data from live endpoints or local files, normalizes heterogeneous resources into a unified schema, and exports PDF/Excel reports with interactive charts. Key contributions include the fully client-side architecture, interactive visualizations, and evaluation showing high transformation accuracy and usability. By removing backend dependencies and enabling offline analysis, the approach lowers the barrier for education, prototyping, and lightweight research in healthcare interoperability, though scalability and broader FHIR profile support remain for future work.
Abstract
The Fast Healthcare Interoperability Resources (FHIR) standard has emerged as a widely adopted specification for exchanging structured clinical data across healthcare systems. However, raw FHIR resources are often complex, verbose, and difficult for clinicians and analysts to interpret without specialized tooling. This paper presents a lightweight, browser-based system that improves the accessibility of FHIR data by automatically transforming raw JSON resources into human-readable PDF and Excel reports, along with interactive data visualizations. The system supports both remote retrieval of FHIR resources from server endpoints and the upload of local FHIR JSON files, enabling both online and offline analysis. Using a modular React architecture with jsPDF, xlsx, and Recharts, the tool parses, normalizes, visualizes, and exports FHIR data in an intuitive format. Evaluation results demonstrate that the system enhances interpretability and usability while preserving the semantic integrity of FHIR structures. Limitations and future extensions, including expanded FHIR profile support and clinical validation, are discussed.
